BRIEF-Lundbeck, Takeda receive CRL from FDA for Trintellix (vortioxetine) sNDA
* Lundbeck and Takeda receive complete response letter from the FDA for Trintellix® (vortioxetine) sNDA
Oct 4 Pharma Foods International :
* Says it will buy 100 percent stake in FUTURE LABO Co.,Ltd at 1.2 billion yen in early Nov.
Source text in Japanese: goo.gl/NNRp0C
Further company coverage: (Beijing Headline News)
June 22 A U.S. judge accepted on Thursday major revisions to Arizona's death penalty procedures, such as eliminating paralytic drugs in lethal injections and giving witnesses more access to watch prisoners inside the death chamber, a lawyer for the death row inmates said.